{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-24-017141","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2024-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.197809+00:00","generated_at":"2026-05-30T21:35:57.846570+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Alzamend Neuro enters ATM offering for up to $6.5M in common stock","bullets":["Entered ATM Sales Agreement with Ascendiant Capital Markets for up to $6.5M of common stock.","Shares sold from time to time at market prices; agent receives customary commission.","Prospectus supplement filed Oct 3, 2024; relies on shelf registration statement 333-273610.","ATM offering provides additional capital but dilutes existing shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-24-017141","json":"https://secwatch.observer/filing/0001214659-24-017141.json","markdown":"https://secwatch.observer/filing/0001214659-24-017141.md","text":"https://secwatch.observer/filing/0001214659-24-017141.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924017141/0001214659-24-017141-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465924017141/g1032408k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T21:35:57.846570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}